A splicing isoform of PD-1 promotes tumor progression as a potential immune checkpoint
2024 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-024-53561-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
187
Citations
8
h-index
8
i10-index
Ao Ding is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA Research and Splicing & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 13 publications.
https://doi.org/10.1038/s41467-024-53561-2
https://doi.org/10.1590/1678-7757-2024-0112
Click to start Chat